Nov 18, 2024, 17:34
Evaluating the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in resected NSCLC – IASLC
IASLC posted on X about recent paper by Tae Hee Hong et al., titled “Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC” published on Journal of Thoracic Oncology.
Authors: Tae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, Chris Abbosh, Tiffany Hung, Jörg Bredno, Jill Walker, Xiaojin Shi, Tsveta Milenkova, Leora Horn, Joon Young Choi, Ho Yun Lee, Jong Ho Cho, Yong Soo Choi, Young Mog Shim, Shoujie Chai, Kate Rhodes, Manami Roychowdhury-Saha, Darren Hodgson, Hong Kwan Kim, Myung-Ju Ahn
“This study aimed to evaluate the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in a large cohort of patients with resected NSCLC. Read more about the findings here!”
Abhijit Dasgupta
cancer
Chris Abbosh
Darren Hodgson
Ho Yun Lee
Hong Kwan Kim
IASLC
Jill Walker
Jong Ho Cho
Joon Young Choi
Jörg Bredno
Journal of Thoracic Oncology
Kate Rhodes
Leora Horn
Manami Roychowdhury-Saha
Myung-Ju Ahn
OncoDaily
Oncology
Shoujie Chai
Soohyun Hwang
Tae Hee Hong
Tiffany Hung
Tsveta Milenkova
Xiaojin Shi
Yong Soo Choi
Young Mog Shim
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 05:54
Dec 21, 2024, 05:42
Dec 21, 2024, 04:55
Dec 21, 2024, 03:42
Dec 21, 2024, 03:31